Corebridge Financial’s Viridian Therapeutics VRDN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-36,556	Closed	-$493K	–	2726
2025 Q1	$493K	Buy	36,556 +220	+0.6%	+$2.97K	﹤0.01%	1608
2024 Q4	$697K	Buy	36,336 +2,878	+9%	+$55.2K	﹤0.01%	1504
2024 Q3	$761K	Sell	33,458 -206	-0.6%	-$4.69K	﹤0.01%	1505
2024 Q2	$438K	Buy	+33,664	New	+$438K	﹤0.01%	1765